This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Apr;11(2):83-6.

doi: 10.1007/s11926-009-0012-6.

A sugar transporter regulates serum urate levels: implications for prevention and management of hyperuricemia in gout

Robert A Terkeltaub¹

Affiliations

PMID: 19296879
DOI: 10.1007/s11926-009-0012-6

Comment

A sugar transporter regulates serum urate levels: implications for prevention and management of hyperuricemia in gout

Robert A Terkeltaub. Curr Rheumatol Rep. 2009 Apr.

. 2009 Apr;11(2):83-6.

doi: 10.1007/s11926-009-0012-6.

Author

Robert A Terkeltaub¹

Affiliation

¹ Department of Medicine, Rheumatology Section, Veterans Affairs Medical Center and the University of California, San Diego, CA, USA. rterkeltaub@ucsd.edu

PMID: 19296879
DOI: 10.1007/s11926-009-0012-6

No abstract available

PubMed Disclaimer

Comment on

Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.
Dehghan A, Köttgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, Boerwinkle E, Levy D, Hofman A, Astor BC, Benjamin EJ, van Duijn CM, Witteman JC, Coresh J, Fox CS. Dehghan A, et al. Lancet. 2008 Dec 6;372(9654):1953-61. doi: 10.1016/S0140-6736(08)61343-4. Epub 2008 Oct 1. Lancet. 2008. PMID: 18834626 Free PMC article.

Similar articles

Identification of GLUT12/SLC2A12 as a urate transporter that regulates the blood urate level in hyperuricemia model mice.
Toyoda Y, Takada T, Miyata H, Matsuo H, Kassai H, Nakao K, Nakatochi M, Kawamura Y, Shimizu S, Shinomiya N, Ichida K, Hosoyamada M, Aiba A, Suzuki H. Toyoda Y, et al. Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18175-18177. doi: 10.1073/pnas.2006958117. Epub 2020 Jul 20. Proc Natl Acad Sci U S A. 2020. PMID: 32690690 Free PMC article.
The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
Eckenstaler R, Benndorf RA. Eckenstaler R, et al. Int J Mol Sci. 2021 Jun 22;22(13):6678. doi: 10.3390/ijms22136678. Int J Mol Sci. 2021. PMID: 34206432 Free PMC article. Review.
Recent approaches to gout drug discovery: an update.
Otani N, Ouchi M, Kudo H, Tsuruoka S, Hisatome I, Anzai N. Otani N, et al. Expert Opin Drug Discov. 2020 Aug;15(8):943-954. doi: 10.1080/17460441.2020.1755251. Epub 2020 Apr 24. Expert Opin Drug Discov. 2020. PMID: 32329387 Review.
ABCG2 as a therapeutic target candidate for gout.
Fujita K, Ichida K. Fujita K, et al. Expert Opin Ther Targets. 2018 Feb;22(2):123-129. doi: 10.1080/14728222.2018.1420167. Epub 2017 Dec 28. Expert Opin Ther Targets. 2018. PMID: 29264928 Review.
A two-stage approach to the treatment of hyperuricemia in gout: the "dirty dish" hypothesis.
Perez-Ruiz F, Herrero-Beites AM, Carmona L. Perez-Ruiz F, et al. Arthritis Rheum. 2011 Dec;63(12):4002-6. doi: 10.1002/art.30649. Arthritis Rheum. 2011. PMID: 21898351

See all similar articles

References

1. PLoS Genet. 2008 Nov;4(11):e1000246 - PubMed
1. PLoS Med. 2008 Oct 7;5(10):e197 - PubMed
1. Nat Genet. 2008 Apr;40(4):437-42 - PubMed
1. Physiol Genomics. 2008 Apr 22;33(2):180-92 - PubMed
1. Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):578-84 - PubMed

Publication types

Actions
Actions
Actions